ENDPOINTS

SK, Carlyle bolster bluebird bio bid; Therini Bio raises $39M

Plus, news about Allogene, Kyverna, Sernova, ADC Therapeutics, Acelyrin, Alumis, Atara, Lava Therapeutics and Repare Therapeutics: SK, Carlyle offer more upfront cash to bluebird bio shareholders: Shareholders can now accept either ...

May 14, 2025 - 16:14
 0
SK, Carlyle bolster bluebird bio bid; Therini Bio raises $39M
Plus, news about Allogene, Kyverna, Sernova, ADC Therapeutics, Acelyrin, Alumis, Atara, Lava Therapeutics and Repare Therapeutics: SK, Carlyle offer more upfront cash to bluebird bio shareholders: Shareholders can now accept either ...
Read More

Tags:

Previous Article

Fossil Suggests Feathered Archaeopteryx Probably Flew Like a Chicken

Next Article

Dopaminergic action prediction errors serve as a value-free teaching signal

Related Posts

Exclusive: Patrick Hsu’s startup Stylus Medicine launches, looks beyond CRISPR for gene insertion tech

Exclusive: Patrick Hsu’s startup Stylus Medicine launch...

May 12, 2025  0

FDA gives AbbVie accelerated approval for antibody-drug conjugate in lung cancer

FDA gives AbbVie accelerated approval for antibody-drug...

May 14, 2025  0

Degradation startup raises $39M for pivot to PROTACs and clinical entry

Degradation startup raises $39M for pivot to PROTACs an...

May 6, 2025  0